CLEC7A and chronic kidney disease: Our data show that the receptor for β-glucan, dectin-1 (CLEC7A) (4, 109), was significantly upregulated in CKD renal specimens (Figure 8B), which demonstrated the potential roles of the β-glucan/dectin-1 pathway in promoting inflammation in CKD.